Gilleece, M. H. Et Al. 2021. Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT. BLOOD CANCER JOURNAL , vol.11, no.5 .

Gilleece, M. H., Shimoni, A., Labopin, M., Robinson, S., Beelen, D., Socie, G., ... Unal, A.(2021). Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT. BLOOD CANCER JOURNAL , vol.11, no.5.

Gilleece, Maria Et Al. "Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT," BLOOD CANCER JOURNAL , vol.11, no.5, 2021

Gilleece, Maria H. Et Al. "Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT." BLOOD CANCER JOURNAL , vol.11, no.5, 2021

Gilleece, M. H. Et Al. (2021) . "Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT." BLOOD CANCER JOURNAL , vol.11, no.5.

@article{article, author={Maria H. Gilleece Et Al. }, title={Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT}, journal={BLOOD CANCER JOURNAL}, year=2021}